In the role of CEO, Joe will manage MassBio’s federal affairs, state and municipal government relations, and will take the lead on initiatives to sustain Massachusetts’ economic competitiveness focusing on issues around infrastructure, workforce, and digital health. Prior to joining MassBio in September 2021, Joe served as the State Senator for the First Suffolk and Middlesex districts, representing his hometown of Winthrop; the Boston communities of East Boston, North End, Chinatown, Beacon Hill, Bay Village, and South End; the Cambridge neighborhoods of Cambridgeport, Riverside and MIT; and the City of Revere. While in the State Senate, Joe was the Chair of the Joint Committee on Transportation, Chair of the Senate’s Committee on Personnel and Administration, Chair of the Joint Committee on Housing, Vice Chair of Rules, and member of the Senate Ways and Means Committee, Senate Ethics Committee, Committee on Bonding, Capital Expenditures and State Assets, and the Committee on Financial Services. Before being elected to the state legislature in 2016, Joe practiced law specializing in criminal law in his private practice and as a public defender with Suffolk Lawyers for Justice. Since his early life, Boncore has been an active member in the Order Sons of Italy in America, he is currently the National Second Vice President. Boncore earned his bachelor’s degree in political science and government from Providence College in 2004 and received his juris doctorate from the Massachusetts School of Law. Joe resides in Winthrop with his wife Christine and twin sons John and Philip.

Kendalle Burlin O’Connell is a seasoned and effective executive who has received wide acclaim for her leadership of MassBio, the world’s largest biopharma membership organization, where she drives the strategy to grow the industry and support member companies as CEO and president. To better serve the entire life cycle of biopharma companies, Kendalle has expanded MassBio’s innovation offerings to include partnering and investor events, an entrepreneurial accelerator, and a network for founders and chief executives. As part of MassBio’s commitment to realizing a more diverse and equitable life sciences industry, Kendalle was the driving force behind the organization’s launch of the non-profit Bioversity and the opening of its first workforce training center in Dorchester where graduates are prepared for rewarding entry-level careers at local life sciences companies. Kendalle has been an outspoken advocate for the industry in policy debates about state government support for the expansion of the life sciences in Massachusetts, the federal government’s intervention into biopharma innovation, and efforts to improve the affordability and accessibility of life-changing medicines, just to name a few. Kendalle has earned numerous accolades for her leadership, including top recognitions from Boston Magazine and the Boston Business Journal, and serves on the Boards of The Boston Foundation and the American Cancer Society, where she is Chair for the Eastern New England region, among others.

Pam Randhawa is CEO and Founder of Empiriko, a biotech company focused on developing R&D technologies for drug discovery and home-based point-of-care devices for personalized patient treatment. Pam has over 20 years of experience in the healthcare and life sciences industries with expertise ranging from policy, corporate strategy, product development, analytics and marketing for Fortune 500 companies, startups and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company using agriculture waste. Previously, Pam held several executive positions with major healthcare technology companies. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce for the Health Status of Ohioans for the State Health Plan to increase access and quality, reduce the cost of healthcare and improve public health in Ohio. Pam serves on the Board of Directors of the Massachusetts Life Sciences Center (MLSC), a state investment agency responsible for $1.6 billion fund to support life sciences innovation and create STEM related jobs in Massachusetts. She also serves on the Board of Directors of the Massachusetts Biotech Technology Council and a member of the World Economic Forum’s Global Future Council on Biotechnology. She chairs NSF/NIJ Industrial Advisory Board of Center for Advanced Research in Forensic Science and a member of the NIH review panel for SBIR/STTR Commercialization Readiness Pilot Program. Pam is a member of the Silent Spring Institute’s Leadership Council which studies the links between the environment and women’s health, with a focus on breast cancer. In addition, she serves on the Economic Development Planning Council for the State of MA. She serves as a judge for the Harvard Business School’s New Venture Competition and provides mentorship to startups and young professionals. Pam holds a bachelor’s degree in economics from the University of Rajasth.